Skip to main content
. 2023 Mar 30;2023(3):CD001233. doi: 10.1002/14651858.CD001233.pub4

Comparison 30. EASI versus intracervical prostaglandin E2: all primiparae.

Outcome or subgroup title No. of studies No. of participants Statistical method Effect size
30.1 Caesarean section 1 70 Risk Ratio (M‐H, Fixed, 95% CI) 0.25 [0.06, 1.09]